Retina

Latest News

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome
Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

June 1st 2023

According to the company, the Phase 1/2 SLO-RP trial completed target enrollment of 48 patients diagnosed with RP associated with USH, with interim efficacy data anticipated by the end of the year.

Optos unveils ultra-widefield color image modality, offering increased retinal visualization to ophthalmologists
Optos unveils ultra-widefield color image modality, offering increased retinal visualization to ophthalmologists

May 30th 2023

Study: Experimental drug inhibits or prevents diabetic eye disease
Study: Experimental drug inhibits or prevents diabetic eye disease

May 29th 2023

Depletion of a certain protein in the body can treat age and diabetes-induced retinal diseases
Depletion of a certain protein in the body can treat age and diabetes-induced retinal diseases

May 29th 2023

Curative Biotechnology files patent on ophthalmic formulation
Curative Biotechnology files patent on ophthalmic formulation

May 25th 2023

Video Interviews
Podcasts
Putting to practice retina innovations amid a pandemic
ASRS 2020: Evaluating 3-year recurrence rate in non-infectious posterior segment veitis (EyePod)
Latest CME Events & Activities

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

The Optometry Times EyeCon 2023

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

More News

© 2023 MJH Life Sciences

All rights reserved.